Inventor Dr. Mehmet Ali SÖYLEMEZ discovered first time, the utility of the biomarker PROCALCITONIN in DIABETES MELLITUS and DIABETIC FOOT SYNDROME. More than 50 peer reviewed* publications have followed, substantiating PROCALCITONIN as one of the most promising biomarker tools for DIABETES MELLITUS and DIABETIC FOOT SYNDROME of healthcare. 1-Plasma procalcitonin and risk of type 2 diabetes in the general population Comparative Study Diabetologia. 2011 Sep;54(9):2463-5. Ali Abbasi et al., UNIVERSITY of CAMBRIDGE , UNITED KINGDOM PMID: 21674177 DOI: 10.1007/s00125-011-2216-3 In type 1 and type … Continue reading “PROCALCITONIN and DIABETES MELLITUS”
PROCALCITONIN and DIABETES MELLITUS
Author mehmetali Posted on September 10, 2020September 15, 2025Categories homePage, Uncategorized 1 Comment on PROCALCITONIN and DIABETES MELLITUS